Cytodyn Inc (CYDY)

[JPG77]

So this is what you referred to as a "saline solution"?? LOL

The results indicated that from day zero to day seven, critically ill patients receiving leronlimab (on day zero) experienced a mortality rate 78% lower than patients receiving placebo.

Further, patients receiving the second dose of leronlimab achieved maximum benefit of 82% less mortality. However, the effects diminished from day 14 to day 21 and from day 21 to day 28, as the mortality rate decreased to 50% and 31%, respectively. The company believe it was due to patients not being administered leronlimab past day 7.

So you think a drug that failed to show it was any better than saline solution in two CoV clinical trials will save lives??